Marco Venturini

3.0k total citations
43 papers, 1.9k citations indexed

About

Marco Venturini is a scholar working on Oncology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marco Venturini has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 15 papers in Cancer Research and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marco Venturini's work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (10 papers) and HER2/EGFR in Cancer Research (9 papers). Marco Venturini is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (10 papers) and HER2/EGFR in Cancer Research (9 papers). Marco Venturini collaborates with scholars based in Italy, United Kingdom and United States. Marco Venturini's co-authors include Lucia Del Mastro, Ornella Garrone, Massimo Costantini, Paola Viterbori, Marco Musso, Francesca Bonci, Gabriella Morasso, Riccardo Rosso, P. Pronzato and Paolo Bruzzi and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marco Venturini

42 papers receiving 1.8k citations

Peers

Marco Venturini
Lothar Häberle Germany
P.F. Bruning Netherlands
E. Wist Norway
Shari Goldfarb United States
Whitfield B. Growdon United States
Koen De Geest United States
Signe Opdahl Norway
Nicole McCarthy Australia
Louise Bordeleau Canada
Shoshana M. Rosenberg United States
Lothar Häberle Germany
Marco Venturini
Citations per year, relative to Marco Venturini Marco Venturini (= 1×) peers Lothar Häberle

Countries citing papers authored by Marco Venturini

Since Specialization
Citations

This map shows the geographic impact of Marco Venturini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Venturini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Venturini more than expected).

Fields of papers citing papers by Marco Venturini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Venturini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Venturini. The network helps show where Marco Venturini may publish in the future.

Co-authorship network of co-authors of Marco Venturini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Venturini. A scholar is included among the top collaborators of Marco Venturini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Venturini. Marco Venturini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gori, Stefania, Matteo Clavarezza, Salvatore Siena, et al.. (2012). Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study. BMC Cancer. 12(1). 158–158. 12 indexed citations
3.
Clavarezza, Matteo, Giorgio Mustacchi, Andrea Casadei‐Gardini, et al.. (2012). Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. BMC Cancer. 12(1). 216–216. 6 indexed citations
4.
Bogina, Giuseppe, Laura Bortesi, Marcella Marconi, et al.. (2011). Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 459(1). 1–10. 52 indexed citations
5.
Mastro, Lucia Del, Luca Boni, Andrea Michelotti, et al.. (2011). Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer. JAMA. 306(3). 269–76. 259 indexed citations
6.
Bedognetti, Davide, Mario Roberto Sertoli, P. Pronzato, et al.. (2011). Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial. JNCI Journal of the National Cancer Institute. 103(20). 1529–1539. 26 indexed citations
7.
Lunardi, Gianluigi, Andrea Armirotti, Lucia Cavallini, et al.. (2009). Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: A case series. Clinical Therapeutics. 31(8). 1812–1819. 22 indexed citations
8.
Mastro, Lucia Del, et al.. (2006). Infertility and pregnancy after breast cancer: Current knowledge and future perspectives. Cancer Treatment Reviews. 32(6). 417–422. 33 indexed citations
9.
Venturini, Marco, Lucia Del Mastro, Enrico Aitini, et al.. (2005). Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(23). 1724–1733. 107 indexed citations
10.
Mastro, Lucia Del, Paolo Bruzzi, Guido Nicolò, et al.. (2005). HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. British Journal of Cancer. 93(1). 7–14. 28 indexed citations
11.
Bertelli, Gianfilippo, et al.. (2004). Sentinel lymph node biopsy in breast cancer patients: The medical oncology perspective. Journal of Surgical Oncology. 85(3). 129–132. 14 indexed citations
12.
Banfi, Andrea, Laura Fazzuoli, Mario Roberto Sertoli, et al.. (2001). High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors. Cancer. 92(9). 2419–2428. 106 indexed citations
13.
Michelotti, Andrea, Marco Venturini, Carmelo Tibaldi, et al.. (2000). Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients. Breast Cancer Research and Treatment. 59(2). 133–139. 19 indexed citations
14.
Pronzato, P., Paola Queirolo, Rita Lionetto, et al.. (2000). Thymidine Labeling Index Analysis in Early Breast Cancer Patients Randomized to Receive Perioperative Chemotherapy. Oncology. 60(1). 88–93. 4 indexed citations
15.
Costantini, Massimo, Marco Musso, Paola Viterbori, et al.. (1999). Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Supportive Care in Cancer. 7(3). 121–127. 464 indexed citations
16.
Bertelli, Gianfilippo, Marco Venturini, Lucia Del Mastro, et al.. (1998). Tamoxifen and the endometrium: findings of pelvic ultrasound examination. Breast Cancer Research and Treatment. 47(1). 41–46. 53 indexed citations
17.
Mastro, Lucia Del, et al.. (1997). Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. Breast Cancer Research and Treatment. 43(2). 183–190. 96 indexed citations
18.
Curotto, Antonio, Luciano Canobbio, Domenico Guarneri, et al.. (1995). Alternating chemo-radiotherapy in bladder cancer: A conservative approach. International Journal of Radiation Oncology*Biology*Physics. 33(1). 173–178. 28 indexed citations
19.
Pagnan, Gabriella, et al.. (1992). Potentiation of Topoisomerase I and II Inhibitors Cell Killing by Tumor Necrosis Factor: Relationship to DNA Strand Breakage Formation. Japanese Journal of Cancer Research. 83(11). 1132–1136. 11 indexed citations
20.
Venturini, Marco, Marco Merlano, Andrea Michelotti, et al.. (1989). Neoadjuvant or Definitive Alternating Chemotherapy and Radiotherapy for Infiltrating Bladder Cancer. American Journal of Clinical Oncology. 12(1). 63–67. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lothar Häberle Breakdown of academic impact, for papers by P.F. Bruning Breakdown of academic impact, for papers by E. Wist Breakdown of academic impact, for papers by Shari Goldfarb Breakdown of academic impact, for papers by Whitfield B. Growdon Breakdown of academic impact, for papers by Koen De Geest Breakdown of academic impact, for papers by Signe Opdahl Breakdown of academic impact, for papers by Nicole McCarthy Breakdown of academic impact, for papers by Louise Bordeleau Breakdown of academic impact, for papers by Shoshana M. Rosenberg
Rankless by CCL
2026